million
polymorphic risk markers for schizophrenia, significantly advancing our understanding
Nurgalieva, A.Kh.,
Bashkatov, S.A.,
Volkova, E.V.,
Petrova, S.G.,
Takhirova, Z.R.,
Mustafin, R.N.,
Fedorova, Y.Y.,
Prokofyeva, D.S.,
Khusnutdinova, E.K. (2023) of future endeavors. There has been conducted a molecular
genetic study of the frequency distribution
Nasyrova, Regina F,
Vaiman, Elena E,
Repkina, Vera V,
Khasanova, Aiperi K,
Asadullin, Azat R,
Shipulin, German A,
Altynbekov, Kuanysh S,
Al-Zamil, Mustafa,
Petrova, Marina M,
Shnayder, Natalia A (2023) genetic studies of the predisposition to the development of AIA. Objective: The goal of our study
Timasheva, Y.,
Balkhiyarova, Z.,
Avzaletdinova, D.,
Rassoleeva, I.,
Morugova, T.V.,
Korytina, G.,
Prokopenko, I.,
Kochetova, O. (2023) We tested associations between 13 established
genetic variants and type 2 diabetes (T2D) in 1371
Korytina, G.F.,
Aznabaeva, Y.G.,
Kochetova, O.V.,
Nasibullin, T.R.,
Akhmadishina, L.Z.,
Khusnutdinova, N.N.,
Zagidullin, N. Sh.,
Victorova, T.V. (2023) the association of cytokines and inflammatory genes
polymorphisms and their combinations with COPD. SNPs